KARA COSSIS: Open Payments
NPI 1831281872 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$49,823 in 122 payments from 19 companies in 2025. Trend: 2023 $36,299 · 2024 $48,424 · 2025 $49,823
Speaker / faculty: $31,038Travel & lodging: $12,961Food & beverage: $3,195Consulting: $2,630
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 39 | $25,254 |
| Janssen Biotech, Inc. | 35 | $16,600 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $6,712 |
| Amgen Inc. | 12 | $518 |
| Radius Health, Inc. | 5 | $209 |
| Tempus AI, Inc | 1 | $103 |
| Globus Medical, Inc. | 1 | $91 |
| BIOPROTECT MEDICAL, INC. | 3 | $69 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Valencia Technologies Corporation | 1 | $32 |
Products named: Xtandi, RYBREVANT, Nubeqa, ERLEADA, EVENITY, Adempas, XT CDX, EXCELSIUS GPS.
Industry payments across MD — which companies pay providers there.
